亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Constitutive androstane receptor (CAR) as a therapeutic target for obesity and type 2 diabetes

詳細技術說明
None
*Abstract
Constitutive androstane receptor (CAR) belongs to the nuclear receptor superfamily of transcriptional factors. CAR has been shown to regulate the expression of drug metabolizing enzymes and transporters. In the current study, the inventors show that CAR plays an important role in regulating energy metabolism and body composition. The findings may establish CAR as a novel therapeutic target for the treatment and/or prevention of obesity and type 2 diabetes .Applications1. Improves body composition2. Prevents high fat diet-induced obesity3. Prevents type 2 diabetesAdvantages1. Increases lean muscle mass2. Decreases body fat3. Increases glucose tolerance on normal or high fat diet; no calorie restriction necessary.Provisional Patent Application filed
*Principal Investigation

Name: Jie Gao, graduate student

Department: Pharm-Office of the Dean


Name: Wen Xie

Department: Pharm-Pharmaceutical Science

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備